Biden’s Cancer Moonshot Won’t Get off the Ground Without Strong IP Protections
The USPTO has launched a new Cancer Moonshot Expedited Examination Pilot Program. The program — which began on February 1, 2023 — expedites the examination of patent applications pertaining to a host of technologies that prevent cancer and cancer mortality. This is a promising measure taken by the Biden administration to encourage IP-based investments in